Aptivus and Confusion - a phase IV clinical study of FDA data
Confusion is reported only by a few people who take Aptivus.
The phase IV clinical study analyzes which people take Aptivus and have Confusion. It is created by eHealthMe based on reports of 945 people who have side effects while taking Aptivus from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
945 people reported to have side effects when taking Aptivus.
Among them, 4 people (0.42%) have Confusion.
What is Aptivus?
Aptivus has active ingredients of tipranavir. eHealthMe is studying from 948 Aptivus users for its effectiveness, alternative drugs and more.
What is Confusion?
Confusion is found to be associated with 3,172 drugs and 2,752 conditions by eHealthMe.
Number of Aptivus and Confusion reports submitted per year:
Time on Aptivus when people have Confusion *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 100 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Confusion when taking Aptivus *:
- female: 0.0 %
- male: 100 %
Age of people who have Confusion when taking Aptivus *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common drugs people take besides Aptivus *:
- Prezista: 4 people, 100.00%
- Truvada: 3 people, 75.00%
- Fuzeon: 3 people, 75.00%
- Bactrim: 3 people, 75.00%
Common side effects people have besides Confusion *:
- Haemorrhage Intracranial (bleeding within the skull): 3 people, 75.00%
- Cerebral Infarction (less blood supply to brain resulting tissue damage): 3 people, 75.00%
- Infarction (obstruction of the blood supply to an organ or region of tissue): 1 person, 25.00%
- Gastrointestinal Disorder (functional problems of gastrointestinal tract): 1 person, 25.00%
Common conditions people have *:
- Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 4 people, 100.00%
- Hiv Infection: 2 people, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Aptivus and have Confusion?Check whether Confusion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Confusion and when was it recovered:
Expand to all the drugs that have ingredients of tipranavir:
Alternative drugs to, pros and cons of Aptivus:
- Aptivus (948 reports)
Confusion treatments and more:
- Confusion (61,170 reports)
COVID vaccines that are related to Confusion:
- Confusion in Moderna COVID Vaccine
- Confusion in Pfizer BioNTech Covid Vaccine
- Confusion in Johnson and Johnson Covid Vaccine
Common drugs associated with Confusion:
- Aspirin: 1,969 reports
- Omeprazole: 1,898 reports
- Prednisone: 1,754 reports
- Furosemide: 1,722 reports
- Metformin: 1,466 reports
- Lorazepam: 1,454 reports
- Loraz: 1,454 reports
- Lasix: 1,397 reports
- Zoloft: 1,318 reports
- Lyrica: 1,311 reports
All the drugs that are associated with Confusion:
- Confusion (3,172 drugs)
Common conditions associated with Confusion:
- Depression: 2,673 reports
- High blood pressure: 2,260 reports
- Pain: 2,092 reports
- Multiple sclerosis: 1,507 reports
- Stress and anxiety: 1,187 reports
All the conditions that are associated with Confusion:
- Confusion (2,752 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tipranavir (the active ingredients of Aptivus) and Aptivus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Pataday vs. Claritin-D 24 Hour - a second ago
- Oramorph Sr vs. Plaquenil - 7 seconds ago
- Flomax and Vitamin B drug interaction - 8 seconds ago
- Demadex vs. Zide - 9 seconds ago
- Pantoprazole Sodium and Coreg Cr drug interaction - 10 seconds ago
- Zoladex vs. Loestrin 24 Fe - 10 seconds ago
- Aloxi and Lyrica drug interaction - 11 seconds ago
- Betapace Af and Death - 13 seconds ago
- Sandostatin and Lyrica drug interaction - 18 seconds ago
- Akineton and Eye Pain - 19 seconds ago